Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in H… Read more
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.007x
Based on the latest financial reports, Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) has a cash flow conversion efficiency ratio of 0.007x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($30.60 Million) by net assets ($4.22 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Tong Ren Tang Chinese Medicine Company Limited - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Beijing Tong Ren Tang Chinese Medicine Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Tong Ren Tang Chinese Medicine Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Westwing Group AG
F:WEW
|
0.221x |
|
Xuchang Ketop Testing Research Ins
SHE:003008
|
0.026x |
|
Designer Brands Inc
NYSE:DBI
|
0.220x |
|
Ohio Valley Banc Corp
NASDAQ:OVBC
|
0.031x |
|
308430
KQ:308430
|
-0.050x |
|
Guangdong Yantang Dairy Co Ltd
SHE:002732
|
0.037x |
|
Newbury Street II Acquisition Corp Class A Ordinary Shares
NASDAQ:NTWO
|
-0.001x |
|
Washington Real Estate Investment Trust
F:WRI
|
0.018x |
Annual Cash Flow Conversion Efficiency for Beijing Tong Ren Tang Chinese Medicine Company Limited (2015–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Tong Ren Tang Chinese Medicine Company Limited from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $546.43 Million | $-217.25 Million | -0.398x | -405.05% |
| 2023-12-31 | $514.77 Million | $67.09 Million | 0.130x | -12.61% |
| 2022-12-31 | $478.60 Million | $71.37 Million | 0.149x | -32.13% |
| 2021-12-31 | $453.87 Million | $99.72 Million | 0.220x | +388.45% |
| 2020-12-31 | $403.61 Million | $18.16 Million | 0.045x | -79.10% |
| 2019-12-31 | $354.94 Million | $76.40 Million | 0.215x | +8.26% |
| 2018-12-31 | $386.27 Million | $76.79 Million | 0.199x | +7.44% |
| 2017-12-31 | $333.64 Million | $61.74 Million | 0.185x | -13.35% |
| 2016-12-31 | $287.27 Million | $61.35 Million | 0.214x | +12.45% |
| 2015-12-31 | $246.31 Million | $46.78 Million | 0.190x | -- |